I thank Drs. Gomez-Mejiba and Ramirez for their letter ([@B1]) and for initiating further discussion of possible mechanisms underlying the effects of 4-1BB stimulation/deficiency on the obesity-induced responses of T cells/macrophages in adipose tissue ([@B2],[@B3]), and how both conditions can lead to protection against metabolic complications.

Obesity-induced adipose inflammation is currently considered to create an optimal environment for autoimmune effects to take root ([@B4]). 4-1BB stimulation with agonistic anti--4-1BB antibody is known to attenuate many autoimmune inflammatory diseases by enhancing the expansion of regulatory T cells (Tregs) and hyperactivating γ-interferon (IFN-γ)--producing CD8^+^ Tregs ([@B5]). Our observations that IFN-γ (IFN-γ itself directly inhibits monocyte migration \[[@B6]\]) and interleukin (IL)-10 increase in response to 4-1BB stimulation ([@B2]) suggest that the anti--4-1BB antibody--induced Tregs suppress the obesity-induced pathogenic responses of inflammatory cells (Th1, CD8^+^ T cells, M1 macrophages) in a manner similar to the way they control autoimmune diseases, and this may ultimately lead to protection against metabolic disorders. Alternatively, it has become clear that the interaction of 4-1BB with 4-1BB ligand (4-1BBL) regulates various inflammatory processes in a bidirectional manner ([@B7],[@B8]), and this often complicates the interpretation of experiments using agonistic anti--4-1BB antibody and/or 4-1BB deletion models ([@B8]). Macrophages express 4-1BBL, and 4-1BBL--mediated reverse signaling on macrophages promotes their proliferation and survival and causes them to release cytokines ([@B8]). Intriguingly, it is likely that agonistic anti--4-1BB antibody blocks the 4-1BBL--mediated inflammatory responses of 4-1BBL--expressing cells by disturbing the 4-1BB/4-1BBL interaction ([@B9]). Hence, 4-1BBL--mediated reverse signaling in adipose macrophages may be suppressed in conditions of both 4-1BB stimulation and deficiency, leading in each case to protecting obesity-induced inflammation and metabolic complications ([@B2],[@B3]). As discussed previously ([@B2],[@B3]), 4-1BB stimulation/deficiency differentially alters cellular responses of immune cells and enhances lipid/glucose metabolism. We suppose that there may be a relationship between 4-1BB/4-1BBL signaling and metabolic pathways, and this possibility is currently under investigation in our laboratory. Elucidation of the mechanisms underlying the effects of 4-1BB/4-1BBL signals on immunometabolism may provide clues to the link between inflammation and metabolism.
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